Skip to main content

AMERIPRISE FINANCIAL INC

Position in URGN — UroGen Pharma Ltd.

CIK 820027 MINNEAPOLIS, MN

Position in URGN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$542,384
-$2,643,180 QoQ
Shares Held
30,166
-77.8% QoQ
Ownership
0.062%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2022
15 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in URGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

AMERIPRISE FINANCIAL INC holds $4,232,542,246 across 191 Biotechnology names. URGN ranks #153 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in URGN

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $542,384 30,166
2025-12-31 $3,185,564 136,019
2025-09-30 $608,155 30,484
2025-06-30 $423,055 30,880
2025-03-31 $373,363 33,758
2024-12-31 $523,479 49,153
2024-09-30 $571,055 44,965
2024-06-30 $756,358 45,075
2024-03-31 $1,064,280 70,952
2023-12-31 $1,094,415 72,961
2023-09-30 $1,206,387 86,109
2023-06-30 $880,164 85,040
2023-03-31 $748,504 81,007
2022-12-31 $718,532 81,007
2022-09-30 $682,647 82,049